Cargando…

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

BACKGROUND AND PURPOSE: Stereotactic body radiotherapy (SBRT) is an emerging modality for definitive treatment of Hepatocellular carcinoma (HCC). MATERIALS AND METHODS: This retrospective study included all early stage HCC patients who were not candidates for primary resection and/or local therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Assaf, Cohen-Naftaly, Michal, Tobar, Anna, Kundel, Yulia, Benjaminov, Ofer, Braun, Marius, Issachar, Assaf, Mor, Eytan, Sarfaty, Michal, Bragilovski, Dimitri, Hur, Ran Ben, Gordon, Noa, Stemmer, Salomon M., Allen, Aaron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649060/ https://www.ncbi.nlm.nih.gov/pubmed/29052532 http://dx.doi.org/10.1186/s13014-017-0899-4

Ejemplares similares

Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience
por: Moore, Assaf, et al.
Publicado: (2016)

Gender specific survival rates after deceased donor liver transplantation: A retrospective cohort
por: Gabbay, Uri, et al.
Publicado: (2022)

Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease
por: Peleg, Noam, et al.
Publicado: (2018)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Liver transplant patients infection rate with SARS-CoV-2 is lower but depend upon the infection rate in the general population and have a better outcome
por: Cohen-Naftaly, Michal, et al.
Publicado: (2022)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
por: Peleg, Noam, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Primary Lung Cancer in Recipients of Lung Transplant
por: Moore, Assaf, et al.
Publicado: (2020)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
por: Brenner, Baruch, et al.
Publicado: (2016)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
por: Kundel, Yulia, et al.
Publicado: (2020)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report
por: Sarfaty, Michal, et al.
Publicado: (2017)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy
por: Fredman, Elisha, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration
por: Burkoň, Petr, et al.
Publicado: (2022)

Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities
por: Shafran, Noa, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
por: Moore, Assaf, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
por: Dagoglu, Nergiz, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for an Extracranial Arteriovenous Malformation of the Pelvis
por: Jooya, Alborz, et al.
Publicado: (2021)

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism
por: Ravid, Amiram, et al.
Publicado: (2019)

Use of Continuous Positive Airway Pressure (CPAP) to Limit Diaphragm Motion—A Novel Approach for Definitive Radiation Therapy for Inoperable Pleural Mesothelioma: A Pilot Study
por: Moore, Assaf, et al.
Publicado: (2021)

A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic solid tumors
por: Stemmer, Salomon M., et al.
Publicado: (2018)

The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis
por: Sarfaty, Michal, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)
por: Wu, Trudy C., et al.
Publicado: (2023)

Applying PET-CT for predicting the efficacy of SBRT to inoperable early-stage lung adenocarcinoma: A Brazilian case-series
por: Moraes, Fabio Y., et al.
Publicado: (2022)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
por: Barney, Brandon M, et al.
Publicado: (2012)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d3cv8todrb1n8vb28pqbr0nhi1